Probuphine

Drug Braeburn Pharmaceuticals, Inc.
Total Payments
$967,451
Transactions
2,755
Doctors
1,107
Companies
3

Payment Trends by Year

Year Amount Transactions Doctors
2023 $3,750 1 1
2021 $8,800 3 1
2020 $61,196 157 103
2019 $149,674 227 111
2018 $96,893 263 153
2017 $647,138 2,104 918

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $341,987 94 35.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $292,650 180 30.2%
Travel and Lodging $273,848 431 28.3%
Food and Beverage $58,820 2,048 6.1%
Gift $146.28 2 0.0%

Top Doctors Receiving Payments for Probuphine — Page 45

Doctor Specialty Location Total Records
, D.O Psychiatry Leawood, KS $10.41 1
, DO Psychiatry Leawood, KS $10.41 1
, MD Psychiatry Leawood, KS $10.41 1
, D.O Psychiatry Kansas City, MO $10.38 1
, M.D Psychiatry Kansas City, MO $10.38 1
, D.O Psychiatry Kansas City, MO $10.37 1
, MD Family Medicine Columbus, OH $10.34 1

About Probuphine

Probuphine is a drug associated with $967,451 in payments to 1,107 healthcare providers, recorded across 2,755 transactions in the CMS Open Payments database. The primary manufacturer is Braeburn Pharmaceuticals, Inc..

Payment data is available from 2017 to 2023. In 2023, $3,750 was paid across 1 transactions to 1 doctors.

The most common payment nature for Probuphine is "Consulting Fee" ($341,987, 35.3% of total).